Covid-19 pandemic

WHO says it ‘cannot cut corners’ in approving India's Covaxin shot

Global health body says expecting ‘one additional piece of information from Bharat Biotech’

WHO says it ‘cannot cut corners’ in approving India's Covaxin shot

Photo for representational purpose only. PTI file

Bengaluru, October 18 

The World Health Organisation on Monday asked for further data from India's Bharat Biotech to consider the company's request for an emergency-use listing for its Covid-19 shot, saying the WHO could not "cut corners" in making a decision.

Bharat Biotech, which developed Covaxin with an Indian state research body, started sharing data with the WHO from early July.

The vaccine was given emergency-use authorisation in India in January even before the completion of a late-stage trial, which later found the shot to be 78% efficacious.

Without a WHO nod, the two-dose Covaxin is unlikely to be accepted as a valid vaccine around the world and would complicate travel plans for tens of millions of Indians who have taken it. Covaxin accounts for 11% of the 985.5 million total doses administered in India, and has also been exported.

"We are aware that many people are waiting for WHO’s recommendation for Covaxin to be included in the #COVID19 Emergency Use Listing, but we cannot cut corners," the WHO said on Twitter.

"Before recommending a product for emergency use, we must evaluate it thoroughly to make sure it is safe and effective." 

The WHO was expecting "one additional piece of information from the company today", it added, without specifying.

Bharat Biotech, which has struggled to meet production timelines for Covaxin, did not immediately respond to Reuters requests for comment.

WHO Chief Scientist Soumya Swaminathan said on Sunday its technical advisory group would meet on October 26 to consider the listing for Covaxin. He said the WHO's goal was to "have a broad portfolio of vaccines approved for emergency use & to expand access to populations everywhere".

India is the world's biggest producer of vaccines, with a capacity to make more than 3 billion Covid shots a year, mainly the AstraZeneca one. Reuters

Tribune Shorts


Top Stories

There is no UPA, Mamata Banerjee after meeting Sharad Pawar

There is no UPA, says Mamata Banerjee after meeting Sharad Pawar

Banerjee is on a three-day visit to Mumbai

International arrivals running smoothly; 1,013 passengers completed arrival formalities: Delhi airport

4 passengers from UK, Netherlands test positive for Covid, samples sent for genome sequencing

All four have been admitted to the LNJP Hospital, where a de...

Mysuru on alert as 72 nursing students test positive for Covid

Mysuru on alert as 72 nursing students test positive for Covid

As many as 43 students of Kaveri Nursing hostel and 29 stude...

Opposition parties stage protest in Parliament complex against suspension of 12 Rajya Sabha MPs

Opposition parties stage protest in Parliament complex against suspension of 12 Rajya Sabha MPs

Former Congress president Rahul Gandhi joins the protest and...

Cities

View All